GAMMA Investing LLC Has $235,000 Holdings in STERIS plc (NYSE:STE)

GAMMA Investing LLC trimmed its holdings in shares of STERIS plc (NYSE:STE) by 13.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,144 shares of the medical equipment provider’s stock after selling 181 shares during the quarter. GAMMA Investing LLC’s holdings in STERIS were worth $235,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its holdings in shares of STERIS by 13.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 6,442,805 shares of the medical equipment provider’s stock valued at $1,414,453,000 after acquiring an additional 778,613 shares during the last quarter. Geode Capital Management LLC boosted its position in STERIS by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock worth $556,786,000 after purchasing an additional 17,007 shares during the period. Principal Financial Group Inc. grew its holdings in STERIS by 9.5% during the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock valued at $270,230,000 after purchasing an additional 96,336 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of STERIS by 12.8% in the second quarter. Dimensional Fund Advisors LP now owns 840,194 shares of the medical equipment provider’s stock valued at $184,439,000 after purchasing an additional 95,412 shares during the period. Finally, Franklin Resources Inc. lifted its stake in shares of STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Stephens reiterated an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research note on Monday, November 18th. Piper Sandler raised STERIS from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $262.50.

STERIS Price Performance

Shares of STE stock opened at $206.30 on Wednesday. The company has a market capitalization of $20.36 billion, a P/E ratio of 47.10 and a beta of 0.84. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock has a 50 day moving average of $214.82 and a two-hundred day moving average of $225.42.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the company earned $2.03 earnings per share. The business’s revenue was up 7.3% compared to the same quarter last year. As a group, equities analysts expect that STERIS plc will post 9.1 EPS for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Tuesday, November 19th were paid a $0.57 dividend. The ex-dividend date was Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.11%. STERIS’s payout ratio is currently 52.05%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.